These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The myoneural effects of propofol emulsion (Diprivan) on the nerve-muscle preparations of rats. Abdel-Zaher AO; Askar FG Pharmacol Res; 1997 Oct; 36(4):323-32. PubMed ID: 9425623 [TBL] [Abstract][Full Text] [Related]
45. Kinetics of (+)-tubocurarine blockade at the neuromuscular junction. Le Dain AC; Madsen BW; Edeson RO Br J Pharmacol; 1991 Jun; 103(2):1607-13. PubMed ID: 1884116 [TBL] [Abstract][Full Text] [Related]
46. Verapamil, neuromuscular transmission and the nicotinic receptor. Edeson RO; Madsen BW; Milne RK; Le Dain AC Eur J Pharmacol; 1988 Jul; 151(2):301-6. PubMed ID: 2844556 [TBL] [Abstract][Full Text] [Related]
47. Tetraethylammonium-methohexitone induced contractures and miniature end-plate potential discharge in the chick biventer cervicis muscle. Elliott RC Gen Pharmacol; 1986; 17(6):655-9. PubMed ID: 3817432 [TBL] [Abstract][Full Text] [Related]
48. Interaction of competitive antagonists: the anti-curare action of hexamethonium and other antagonists at the skeletal neuromuscular junction. Blackman JG; Gauldie RW; Milne RJ Br J Pharmacol; 1975 May; 54(1):91-100. PubMed ID: 166720 [TBL] [Abstract][Full Text] [Related]
49. A potent factor in extracts of the skin of the Australian frog, Pseudophryne coriacea--III. Potentiation of contractions elicited in avian and mammalian isolated skeletal muscle preparations by direct and indirect electrical stimulation. Falconieri Erspamer G; Erspamer V; Melchiorri P Neuropharmacology; 1986 Aug; 25(8):807-14. PubMed ID: 3022175 [TBL] [Abstract][Full Text] [Related]
50. The neuromuscular blocking activity of spectinomycin on the rat sciatic nerve-gastrocnemius muscle preparation. Renna G; Cagiano R; Fiore T; Cuomo V Pharmacol Res Commun; 1986 May; 18(5):451-7. PubMed ID: 3016766 [TBL] [Abstract][Full Text] [Related]
51. Facilitation of Neuromuscular transmission by calcium antagonists, diltiazem, nifedipine and verapamil, in the dog. Sato T; Ono H Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):235-46. PubMed ID: 6261709 [TBL] [Abstract][Full Text] [Related]
52. Effects of ganglionic blocking agents on the neuromuscular junction. Chiou CY Eur J Pharmacol; 1970; 12(3):342-7. PubMed ID: 4395556 [No Abstract] [Full Text] [Related]
56. The autonomic margins of safety of metocurine and d-tubocurarine in the cat. Savarese JJ Anesthesiology; 1979 Jan; 50(1):40-6. PubMed ID: 83803 [TBL] [Abstract][Full Text] [Related]
57. Interaction of adrenaline with neostigmine and tubocurarine at the skeletal neuromuscular junction. Drury PJ; Birmingham AT; Healy TE Br J Anaesth; 1987 Jun; 59(6):784-90. PubMed ID: 3606921 [TBL] [Abstract][Full Text] [Related]
58. Actions of polypeptides at the neuromuscular junction. Wali FA Agents Actions; 1985 Sep; 16(6):558-66. PubMed ID: 2416208 [TBL] [Abstract][Full Text] [Related]
59. Assessment of the presynaptic effect of atracurium. Train-of-four and tetanic stimulation in in vitro preparations. Wali FA Acta Anaesthesiol Scand; 1985 Oct; 29(7):657-62. PubMed ID: 3840945 [TBL] [Abstract][Full Text] [Related]
60. In vitro comparison between the neuromuscular and ganglion blocking potency ratios of atracurium and tubocurarine. Healy TE; Palmer JP Br J Anaesth; 1982 Dec; 54(12):1307-11. PubMed ID: 6293522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]